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DOI 10.1016/j.immuni.2010.01.006In the August 2009 issue of Immunity
(volume 31, number 2), we read with great
interest two articles that were written
by Martin et al. (2009) and Sutton et al.
(2009) and that focused on interleukin-17
(IL-17)-producing gd T cells. We were,
however, surprised to find that both of
these papers claim priority for showing
that gd T cells can produce IL-17 with-
out deliberate stimulation via the T cell
receptor (TCR). We feel that this claim is
unwarranted because in fact at least two
previously published papers also arrived
at this conclusion (but were not quoted
by the authors of either of these Immunity
papers). First, Shibata et al. (2007) showed
by intracellular cytokine staining that
50% of peritoneal cells from naive mice,
when cultured with recombinant IL-23
only in vitro for 7 hr, produce IL-17.
Second, Cheng et al. (2008) found that
gd T cells purified from mice immunized
with a retinal protein-derived peptide,
when cultured with a mixture of IL-1,
IL-7, and IL-23 but without antigen, were
likewise stimulated to produce IL-17.
Furthermore, both papers run into diffi-
culties when they attempt to determine
which subset of gd T cells is responding
in their systems by looking at expressed
TCR elements among the IL-17-pro-
ducing gd T cells. Sutton et al. claim to
have examined ‘‘Vg4 and Vg5’’ expres-
sion. Although it makes sense to look for
Vg4+ gd T cells, because they were found
to almost exclusively represent the IL-
17-producing population in the draining
lymph nodes of mice with collagen-
induced arthritis (Roark et al., 2007) and
Sutton et al. indeed refer to this work, it
really does not makes sense to look for
Vg5+ cells, which are observed only in
the murine epidermis both normally and
during inflammation. The cells examined
by Sutton et al. were instead probably
the Vg7+ population because they found
that more than 30% of the gd T cells infil-
trating the brains of mice with EAE, and17% of those in spleen, expressed this
Vg chain. The apparent confusion here
probably stems from the fact that this
subset is also known as ‘‘Vg5’’ by an alter-
nate nomenclature (Garman et al., 1986),
even though Sutton et al. refer to the other
subset as ’’Vg4’’ in accordance with the
nomenclature of Heilig and Tonegawa
(1986). Sutton et al. also look for expres-
sion of Vd6.3 in the IL-17+ gd T cells, but
do not explain why they did not instead
look for Vd4, which would have been the
logical choice because virtually all of
the Vg4+ cells producing IL-17 in the
collagen-induced arthritis model coex-
pressed Vd4. In the paper by Martin
et al. (which uses the alternate nomencla-
ture [Garman et al., 1986]), a potentially
more seriousmistake ismade: the authors
use two different models to examine gd
T cells; in both, the mice are injected
with complete Freund’s adjuvant (IFA plus
heat-killed mycobacteria), but sometimes
by a subcutaneous and sometimes by an
intraperitoneal route. Our recent experi-
ments show that differentmodes of immu-
nization with CFA give rise to predominant
IL-17 responses by completely different
gd T cell subsets. Whereas the intra-
dermal route of immunization (and prob-
ably also the subcutaneous route used
by Martin et al.) preferentially stimulates
a Vg4Vd4+ subset having well-defined
TCR junctional motifs (Roark et al., 2007
and Figure S1A available online), the
intraperitoneal route mainly expands gd
T cells with a different TCR (Figure S1B).
Because TCR-defined gd T cells subsets
often differ functionally from one another
(O’Brien et al., 2007), Martin et al. were
thus probably comparing apples with
oranges in their study.
Finally, with regard to the question of
whether gd T cells require prior TCR stim-
ulation to produce IL-17, the authors do
not appear to have considered the possi-
bility that the responding gd T cells in their
systems may have already encounteredImmunitya ligand and would not have responded
in vitro to cytokines only were it not for
that. If ligands for gd T cells are, as is
commonly speculated, stress-induced
host molecules, they could well already
have encountered a ligand. In the study
by Shibata et al. (2007), gd T cells from
naive mice instead were used for exam-
ining this question, implying that TCR
stimulation is indeed not necessary.
However, as noted in Martin et al. (2009),
normal peritoneal Vg6Vd1+ gd T cells
show very high expression of CD44,which
may mean they have been previously
TCR-stimulated in some way and then
recruited to the peritoneum. If these
were CD4+ ab T cells, it would probably
have been assumed that such cells repre-
sent preactivated or memory cells.
SUPPLEMENTAL INFORMATION
Supplemental Information includes one figure
and can be found with this article online at doi:10.
1016/j.immuni.2010.01.006.
REFERENCES
Cheng, L., Cui, Y., Shao, H., Han, G., Zhu, L.,
Huang, Y., O’Brien, R.L., Born, W.K., Kaplan, H.J.,
and Sun, D. (2008). J. Neuroimmunol. 203, 3–11.
Garman, R.D., Doherty, P.J., and Raulet, D.H.
(1986). Cell 45, 733–742.
Heilig, J.S., and Tonegawa, S. (1986). Nature 322,
836–840.
Martin, B., Hirota, K., Cua, D.J., Stockinger, B., and
Veldhoen, M. (2009). Immunity 31, 321–330.
O’Brien, R.L., Roark, C.L., Jin, N., Aydintug, M.K.,
French, J.D., Chain, J.L., Wands, J.M., Johnston,
M., and Born, W.K. (2007). Immunol. Rev. 215,
77–88.
Roark, C.L., French, J.D., Taylor, M.A., Bendele,
A.M., Born, W.K., and O’Brien, R.L. (2007).
J. Immunol. 179, 5576–5583.
Shibata, K., Yamada, H., Hara, H., Kishihara, K.,
and Yoshikai, Y. (2007). J. Immunol. 178, 4466–
4472.
Sutton, C.E., Lalor, S.J., Sweeney, C.M., Brereton,
C.F., Lavelle, E.C., and Mills, K.H. (2009). Immunity
31, 331–341.32, January 29, 2010 ª2010 Elsevier Inc. 1
